• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Wanbury Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524212
INE107F01022
41.3185648
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WANBURY
11.54
684.83
EPS(TTM)
Face Value()
Div & Yield %
16.97
10
0
 

sobha ltd
CreditAccess Grameen successfully raises Rs 300 cr via NCDs
Sep 03,2026

CreditAccess Grameen has successfully raised Rs 300 crore in September 2026 through private placement of non-convertible debentures (NCDs). The issue launched was fully subscribed and bilaterally placed with Barclays Bank PLC, a qualified institutional buyer.

The Company continues to tap the private placement NCD route to fund the growth of its lifecycle credit suite for low-middle income households across rural and semi-urban India.

The NCDs are senior, secured, rated, listed, and redeemable in nature. The NCDs were issued in two tranches – i) Rs 100 crore with a tenure of 24 months carrying a fixed rate coupon of 9.15% per annum and ii) Rs 200 crore with a tenure of 36 months carrying a fixed rate coupon of 9.25% per annum. The coupon on both tranches is payable annually, with the principal repayable as a bullet payment at the end of the respective tenures.